NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
NASDAQ: ENSC 73.31%
Expected US Company Earnings on Tuesday, November 11th, 2025
OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NASDAQ: CDIO 32.65%
BioMedNewsBreaks - Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) Schedules Investor Conference Call for Feb. 19, 2026
OTC: DBLVF 24.07%
Top 5 Canadian Mining Stocks This Week: Adex Mining Shines with 171 Percent Gain
OTC: NGNE 77.39%
OTC: KORE 77.39%
OTC: ENSC 77.39%
OTC: ACXIF 77.39%
OTC: CDIO 77.39%
